1. Home
  2. IMPP vs NKTX Comparison

IMPP vs NKTX Comparison

Compare IMPP & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imperial Petroleum Inc.

IMPP

Imperial Petroleum Inc.

HOLD

Current Price

$4.12

Market Cap

162.3M

ML Signal

HOLD

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$1.84

Market Cap

133.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMPP
NKTX
Founded
1981
2015
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.3M
133.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
IMPP
NKTX
Price
$4.12
$1.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$5.50
$13.25
AVG Volume (30 Days)
1.2M
650.8K
Earning Date
12-11-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.03
N/A
Revenue
$136,071,654.00
N/A
Revenue This Year
$9.69
N/A
Revenue Next Year
$51.33
N/A
P/E Ratio
$4.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.12
$1.31
52 Week High
$6.57
$2.74

Technical Indicators

Market Signals
Indicator
IMPP
NKTX
Relative Strength Index (RSI) 35.19 45.33
Support Level $4.04 $1.81
Resistance Level $4.49 $1.90
Average True Range (ATR) 0.38 0.07
MACD -0.12 0.02
Stochastic Oscillator 4.05 52.50

Price Performance

Historical Comparison
IMPP
NKTX

About IMPP Imperial Petroleum Inc.

Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: